跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TREMFYA ONE-PRESS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TREMFYA ONE-PRESS
Authorized
STANDARD
TREMFYA ONE-PRESS
Janssen Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7bca8b4366d13bd1
Company
Janssen Inc
Type
Standard
Approval Details
Approval Id
7bca8b4366d13bd1
Drug Approval Canada Name
TREMFYA ONE-PRESS
Product Name
TREMFYA ONE-PRESS
Status
Marketed
Status Date
2019-05-20
Original Market Date
2019-05-20
Din
02487314
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D , Prescription
Ahfs
84:06.28
Atc Original
L04AC16 GUSELKUMAB
Atc Name
l 04 ac 16
Aig Number
0159710001
Company Name
Janssen Inc
Company Address
19 Green Belt Drive, Toronto, Ontario, Canada, M3C 1L9
Company Detail Path
/organization/janssen-inc
Company Information
Pharmaceutical Company Name
Janssen Inc
Country Name
Canada
Province Name
Ontario
City Name
north york,ontario,country_ca
Address
19 Green Belt Dr
Active Ingredients
GUSELKUMAB
100 MG / 1 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7bca8b4366d13bd1
Type
Standard
Back to Health Canada Approvals